TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Alkermes Plc?
What does OpenAI free version (gpt-3.5-turbo) know about Alkermes Plc?
Last request | 14.12.2023 |
Well Known | Yes |
Description | Alkermes Plc is a biopharmaceutical company that develops innovative medicines for central nervous system (CNS) diseases. |
Most Notable Achievements | Alkermes Plc has a strong commitment to developing innovative treatments for CNS diseases. |
The Most Negative Fact | Alkermes Plc has faced some legal issues in the past. |
Competition | None |
Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Alkermes Plc?
Request date | |
Well Known | Yes |
Description | Biopharmaceutical company that develops and commercializes medicines for the treatment of central nervous system diseases and addiction |
Most Notable Achievements | Their drug Vivitrol has been shown to reduce opioid relapse rates |
The Most Negative Fact | Controversy surrounding the pricing of their drug Vivitrol |
Competition | None |
Share with friends |
What does Google AI (PaLM) know about Alkermes Plc?
Last request | 14.12.2023 |
Well Known | yes |
Description | Alkermes plc is a pharmaceutical company based in Dublin, Ireland. It was founded in 1987 by Dr. John F. Crowley and Dr. Kevin J. O'Reilly. The company's primary focus is on the development and commercialization of treatments for central nervous system disorders. |
Most Notable Achievements | Alkermes plc has a strong track record of developing and commercializing innovative treatments for central nervous system disorders. The company's products are used to treat a variety of conditions, including schizophrenia, bipolar disorder, and opioid addiction. |
The Most Negative Fact | Alkermes plc has been criticized for its high prices for its products. The company's drugs are often priced at a premium compared to other treatments for the same conditions. |
Competition | None |
What does Microsoft Bing AI know about Alkermes Plc?
Well Known | Yes |
Description | eitdseys)aeepdms f.ovchusovctam mc ednuairssia o eec cNnAr iimaPoen syeailat toesnatlnelhrlv ca e nsvteork( lsrSCmpi pbi |
Most Notable Achievements | neiaggekhttoimctmisanrNeaiort l n se .dmvAv ott oonsees sdeSmatr irplem ocePf Ctn snalevs |
The Most Negative Fact | uafcl ms estoiAeaalsts skmihlree e sPee sd hnpclga . |
Competition | eoNn |